Related Experiment Videos
[Neuronal ceroid lipofuscinosis. An unknown overload disease]
A Echaniz-Laguna1, C Tranchant, N Boehm
1Service des Maladies du Système nerveux et du Muscle, Hôpital Civil de Strasbourg.
Presse Medicale (Paris, France : 1983)
|May 25, 1996
Summary
Neuronal ceroid lipofuscinosis are rare genetic lysosomal diseases causing vision loss, dementia, and seizures in children. Diagnosis involves skin biopsies and genetic testing, with limited treatment options.
Area of Science:
- Genetics
- Neurology
- Cell Biology
Context:
- Neuronal ceroid lipofuscinosis (NCL) are a group of inherited lysosomal storage diseases.
- Often underdiagnosed, NCL presents with progressive vision loss, cognitive decline, and seizures, particularly in pediatric populations.
- Key pathological features include the accumulation of autofluorescent lipopigments within cellular lysosomes, especially in neurons.
Purpose:
- To outline the clinical presentation and diagnostic approaches for Neuronal ceroid lipofuscinosis.
- To highlight the genetic basis and pathological hallmarks of NCL.
- To emphasize the current limitations in understanding NCL pathophysiology and treatment.
Summary:
- NCL encompasses autosomal recessive lysosomal diseases presenting with blindness, dementia, and myoclonic seizures in children and adolescents.
- Characteristic lipopigment accumulation in neurons and specific lysosomal inclusions in skin biopsies aid diagnosis.
- Genetic mutations in CLN1, CLN3, and CLN5 genes can be identified in affected children.
Impact:
- Enhances recognition of NCL in clinical practice, particularly in pediatric neurology and ophthalmology.
- Provides a concise overview of diagnostic tools, including histology and genetic testing for NCL.
- Underscores the need for further research into NCL pathophysiology and the development of effective therapeutic strategies.